During the past decade, Hospital Universitário João de Barros Barreto conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 7 clinical trials were completed, i.e. on average, 175% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitário João de Barros Barreto" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitário João de Barros Barreto" are "Diabetes Mellitus, Type 2" (3 trials), "Cardiovascular Disease" (2 trials), "Diabetes Mellitus" (2 trials), "Gastroparesis" (2 trials) and "Kidney Disease, Chronic" (1 trials). Many other conditions were trialed in "Hospital Universitário João de Barros Barreto" in a lesser frequency.

Most popular intervention types in "Hospital Universitário João de Barros Barreto" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Relamorelin" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Alogliptin Benzoate" (1 trials) and "BI 690517" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitário João de Barros Barreto" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universitário João de Barros Barreto". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Universitário João de Barros Barreto, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitário João de Barros Barreto, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".